BMY

BRISTOL MYERS SQUIBB CO

Health Care · Pharmaceuticals

$174.15 sample

-0.90 (-0.51%) 1D

Market cap

$195.7B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-06

Alerts

8

Price$174.15 -4.93% 3M daily closessample

196.22174.15

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 06SEC8-K filed: material event
Sep 28INSInsider sell: Chief Financial Officer
Sep 22SEC8-K filed: material event
Sep 16INSInsider sell: General Counsel
Sep 07INSInsider sell: Chief Financial Officer
Aug 27INSInsider buy: EVP, Operations
Aug 21INSInsider sell: Chief Financial Officer
Aug 17INSInsider sell: 10% owner

Sign up to see the real BMY record →

Company facts

SEC EDGAR registration

Name: BRISTOL MYERS SQUIBB CO
Sector: Health Care
Industry: Pharmaceuticals
Smart-money score: -39sample, -100 to +100
Reporting currency: USD

Who is positioning in BMY

sample

Insiders: 14 insider transactions over 90 days, net selling, $856.6M
Congress: 3 members traded over 90 days
Institutions · 13F: 7 funds hold $4.2B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$10.9B +10.4% y/y

Q4 2024Q3 2026

Inventory$6.7B +19.0% y/y

Q4 2024Q3 2026

Accounts receivable$4.8B +8.9% y/y

Q4 2024Q3 2026

Total debt$12.9B +6.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $29.0B -13.0% 3M
Sample peer B: $92.7B -12.5% 3M
Sample peer C: $33.0B +14.4% 3M
Sample peer D: $33.2B -5.9% 3M
Sample peer E: $177.3B -6.1% 3M